• Fourth Quarter Net Sales Increase 14% to $60.3 Million
• First $1.0 Million NanoKnife(R) IRE System Net Sales Quarter
• Record $16.1 Million Operating Cash Flow Quarter
• Fourth Quarter Net Income Grows 29%
• Company Provides Guidance for FY 2011
• Conference Call Begins Today at 4:30 p.m. Eastern Time

ALBANY, N.Y., Jul 12, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) announced today the global expansion of its Smart Port CT family of power-injectable ports, featuring its patented Vortex (R) port technology - to include low-profile and mini models for repeated treatments such as

ALBANY, N.Y., Jun 17, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2010 fourth quarter and full year financial

ALBANY, N.Y., May 20, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO) today announced the appointment of Lynda Wallace, 47, as Senior Vice President of Business Development. In this capacity, Ms. Wallace will lead AngioDynamics' business development and strategic planning activities and join

Company Now Offers Full Line of Peripherally Inserted Central Catheters

New Centros Catheter Features an Enhanced Tip Design to Optimize Blood Flow

ALBANY, N.Y., May 04, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Bank of America Merrill Lynch Health Care

Segment expected to highlight advantages of new gold-tip NeverTouch® laser fiber

ALBANY, N.Y., Apr 27, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Deutsche Bank 35 th Annual Health Care Conference

Seven Medical Centers in Europe to Participate in Clinical Trial

• Net Sales Increase 6% to $52.2 million
• NanoKnife^(R) IRE System Net Sales of $724,000
• Net Income of $3.3 Million, or $0.13 EPS
• Operating Cash Flow of $11.4 Million
• Company Reiterates Fiscal 2010 Guidance
• Conference Call Begins Today at 4:30 p.m. Eastern Time

Location leverages Albany International Airport, Resources of New York's Tech Valley

Book Explores IRE Technology Featured in AngioDynamics' NanoKnife System

QUEENSBURY, N.Y., Mar 15, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it has changed the date that it will report its fiscal 2010 third

QUEENSBURY, N.Y., Mar 11, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2010 third quarter financial results on

More on the procedure can be found at www.venacure-evlt.com

QUEENSBURY, N.Y., Jan 07, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 28th Annual J.P.

• Net Sales Increase 10% to $53.5 Million
• NanoKnife^(R) IRE System Net Sales of $700,000
• Net Income Increase of 8% to $3.1 Million, or $0.13 EPS
• Operating Cash Flow of $11.2 Million
• Conference Call Begins Today at 4:30 p.m. Eastern Time

New Options Provide Physicians with Comprehensive Product Line from Single Source

New Catheter Completes Drainage Product Portfolio